Variables | PERCIST | iPERCIST |
---|
Responder | Non-responder | Total | (κ) | Responder | Non-responder | Total | (κ) |
---|
EORTC criteria |
SULpeak |
Responder | 16 | 4 | 20 | (κ = 0.71) | 13 | 7 | 20 | (κ = 0.62) |
Non-responder | 3 | 31 | 34 | 2 | 32 | 34 |
Total | 19 | 35 | 54 | 15 | 39 | 54 |
MTV |
Responder | 12 | 2 | 14 | (κ = 0.89) | 12 | 2 | 14 | (κ = 0.89) |
Non-responder | 0 | 40 | 40 | 0 | 40 | 40 |
Total | 12 | 42 | 54 | 12 | 42 | 54 |
TLG |
Responder | 15 | 2 | 17 | (κ = 0.91) | 15 | 0 | 15 | (κ = 0.91) |
Non-responder | 0 | 47 | 47 | 2 | 37 | 39 |
Total | 15 | 49 | 54 | 17 | 37 | 54 |
- Abbreviations: CT Computed tomography, PET Positron emission tomography, RECIST Response Evaluation Criteria Solid in Tumors, irRECIST Immune modified Response Evaluation Criteria Solid in Tumors, PERCIST PET Evaluation Criteria in Solid Tumors, iPERCIST Immune modified Response Evaluation Criteria Solid in Tumors, EORTC European Organization for Research and Treatment of Cancer, SULpeak The peak standardized uptake value normalized by lean body mass, MTV Metabolic tumor volume, TLG Total lesion glycolysis, (κ) The value of agreement between two assessments using Cohen κ coefficient